Add-on pralidoxime therapy did not offer any appreciable benefit over atropine alone in terms of reducing mortality ( @ % ( @/@ ) versus @ % ( @/@ ) ) and ventilator requirement ( @ % ( @/@ ) versus @ % ( @/@ ) ) .